7.0(top 5%)
impact factor
8.9K(top 2%)
papers
359.3K(top 1%)
citations
217(top 1%)
h-index
11.3(top 2%)
extended IF
11.0K
all documents
380.7K
doc citations
356(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis20066,200
2Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis20204,792
3Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patientsJournal of Thrombosis and Haemostasis20053,953
4Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathyJournal of Thrombosis and Haemostasis20203,028
5Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patientsJournal of Thrombosis and Haemostasis20101,921
6ISTH interim guidance on recognition and management of coagulopathy in COVID‐19Journal of Thrombosis and Haemostasis20201,571
7Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis20201,521
8Fibrinogen and fibrin structure and functionsJournal of Thrombosis and Haemostasis20051,418
9Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapyJournal of Thrombosis and Haemostasis20071,371
10Incidence of venous thromboembolism in hospitalized patients with COVID‐19Journal of Thrombosis and Haemostasis20201,273
11Incidence and mortality of venous thrombosis: a population-based studyJournal of Thrombosis and Haemostasis20071,161
12Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasisJournal of Thrombosis and Haemostasis20201,116
13Update of the guidelines for lupus anticoagulant detectionJournal of Thrombosis and Haemostasis20091,074
14Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand FactorJournal of Thrombosis and Haemostasis20061,073
15D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19Journal of Thrombosis and Haemostasis20201,028
16High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patientsJournal of Thrombosis and Haemostasis20201,014
17Definition of clinically relevant non‐major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non‐surgical patients: communication from the SSC of the ISTHJournal of Thrombosis and Haemostasis2015963
18Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trialJournal of Thrombosis and Haemostasis2007945
19Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settingsJournal of Thrombosis and Haemostasis2006932
20Protease‐activated receptors in hemostasis, thrombosis and vascular biologyJournal of Thrombosis and Haemostasis2005925
21A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction ScoreJournal of Thrombosis and Haemostasis2010913
22Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysisJournal of Thrombosis and Haemostasis2010834
23The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndromeJournal of Thrombosis and Haemostasis2020819
24Neutrophil extracellular traps promote deep vein thrombosis in miceJournal of Thrombosis and Haemostasis2012762
25Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensingJournal of Thrombosis and Haemostasis2014738
26Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrelJournal of Thrombosis and Haemostasis2007676
27The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhageJournal of Thrombosis and Haemostasis2007644
28ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disordersJournal of Thrombosis and Haemostasis2010635
29Thrombopoietin: a tool for understanding thrombopoiesisJournal of Thrombosis and Haemostasis2003623
30Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentrationJournal of Thrombosis and Haemostasis2014602
31Multiple roles of the endothelial cell protein C receptorJournal of Thrombosis and Haemostasis2007590
32Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage studyJournal of Thrombosis and Haemostasis2006583
33Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA studyJournal of Thrombosis and Haemostasis2008574
34Definitions in hemophilia: communication from the SSC of the ISTHJournal of Thrombosis and Haemostasis2014572
35Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19Journal of Thrombosis and Haemostasis2020570
36In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939—an oral, direct Factor Xa inhibitorJournal of Thrombosis and Haemostasis2005566
37The platelet contribution to cancer progressionJournal of Thrombosis and Haemostasis2011566
38Fibrin structure and wound healingJournal of Thrombosis and Haemostasis2006559
39Thromboinflammation and the hypercoagulability of COVID‐19Journal of Thrombosis and Haemostasis2020550
40Efficacy and safety of recombinant human soluble thrombomodulin (ART‐123) in disseminated intravascular coagulation: results of a phase III, randomized, double‐blind clinical trialJournal of Thrombosis and Haemostasis2007543
41A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)1Journal of Thrombosis and Haemostasis2005541
42Clinical course of high‐risk patients diagnosed with antiphospholipid syndromeJournal of Thrombosis and Haemostasis2010541
43Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?Journal of Thrombosis and Haemostasis2007509
44What is all that thrombin for?Journal of Thrombosis and Haemostasis2003490
45Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomesJournal of Thrombosis and Haemostasis2012487
46A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD)Journal of Thrombosis and Haemostasis2006486
47Pathological evidence of pulmonary thrombotic phenomena in severe COVID‐19Journal of Thrombosis and Haemostasis2020486
48Platelet functions beyond hemostasisJournal of Thrombosis and Haemostasis2009485
49International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerJournal of Thrombosis and Haemostasis2013476
50Coagulopathy in COVID‐19Journal of Thrombosis and Haemostasis2020476